Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
145 participants
OBSERVATIONAL
2005-08-31
2020-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?
NCT01837745
Radiofrequency Ablation Versus I-131 for Solitary Autonomous Thyroid Nodules
NCT05142904
Systematic Radioiodine Administration Versus Decision of Radioiodine Treatment Guided by a Post-operative Work-up
NCT04290663
Assessing the Impact of the Early and Systematic Hormonal Replacement After Radio-isotopic Ablation of Graves'hyperthyroïdism on Quality of Life, Efficiency and Tolerance
NCT01295333
Comparison of Dosimetry After rhTSH or Withdrawal of Thyroid Hormone in Metastatic or Locally Advanced Thyroid Cancer
NCT01403324
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Isolated decreased thyroid-stimulating hormone (TSH) with normal FT4 and FT3 levels
Exclusion Criteria
* Non sinusal heart rhythm
* Severe heart disease
50 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Bernard Goichot, MD
Role: PRINCIPAL_INVESTIGATOR
Hopitaux Universitaires de Strasbourg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Patrick Roger
Bordeaux, , France
Philippe Thiéblot
Clermont-Ferrand, , France
Jean-Marcel Brun
Dijon, , France
Jean-Louis Wemeau
Lille, , France
Marie-Pierre Teissier
Limoges, , France
Jacques Orgiazzi
Lyon, , France
Bernard Conte-Delvox
Marseille, , France
CH de Montbrison
Montbrison, , France
Jacques Bringer
Montpellier, , France
Marc Klein
Nancy, , France
Michel Rodier
Nîmes, , France
Laurence Leenhardt
Paris, , France
Richard Marechaud
Poitiers, , France
Brigitte Delemer
Reims, , France
Claire Schvartz
Reims, , France
Jean-Marc Kuhn
Rouen, , France
Bruno Estour
Saint-Etienne, , France
Centre Paul Strauss
Strasbourg, , France
Hopitaux Universitaires de Strasbourg
Strasbourg, , France
Philippe Caron
Toulouse, , France
Pierre Lecomte
Tours, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
3463
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.